Zhang F - Search Results

1

Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma.

Song TL, Nairismägi ML, Laurensia Y, Lim JQ, Tan J, Li ZM, Pang WL, Kizhakeyil A, Wijaya GC, Huang DC, Nagarajan S, Chia BK, Cheah D, Liu YH, Zhang F, Rao HL, Tang T, Wong EK, Bei JX, Iqbal J, Grigoropoulos NF, Ng SB, Chng WJ, Teh BT, Tan SY, Verma NK, Fan H, Lim ST, Ong CK. Song TL, et al. Among authors: zhang f. Blood. 2018 Sep 13;132(11):1146-1158. doi: 10.1182/blood-2018-01-829424. Epub 2018 Jul 27. Blood. 2018. PMID: 30054295 Free PMC article.

2

Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients.

Liu YH, Xu FP, Zhuang HG, Lai KC, Xie D, Luo DL, Li L, Luo XL, Xu J, Zhang MH, Zhang F, Li HM. Liu YH, et al. Among authors: zhang mh, zhang f. Hum Pathol. 2008 Jun;39(6):875-84. doi: 10.1016/j.humpath.2007.10.013. Epub 2008 Apr 28. Hum Pathol. 2008. PMID: 18440593

3

[Clinicopathologic significance of bcl-6 gene rearrangement and expression in three molecular subgroups of diffuse large B-cell lymphoma].

Xu FP, Liu YH, Luo XL, Zhuang HG, Li L, Luo DL, Xu J, Zhang F, Zhang MH, Du X, Li WY. Xu FP, et al. Among authors: zhang mh, zhang f. Zhonghua Bing Li Xue Za Zhi. 2008 Jun;37(6):371-6. Zhonghua Bing Li Xue Za Zhi. 2008. PMID: 19031715 Chinese.

4

[Clinicopathologic study of pulmonary adenocarcinoma with features of bronchioloalveolar carcinoma].

Luo DL, Liu YH, Zhuang HG, Liao RQ, Luo XL, Xu FP, Zhang F. Luo DL, et al. Among authors: zhang f. Zhonghua Bing Li Xue Za Zhi. 2008 Nov;37(11):737-42. Zhonghua Bing Li Xue Za Zhi. 2008. PMID: 19094707 Chinese.

5

[Extranodal nasal type NK/T-cell lymphoma: clinicopathologic and prognostic study of 55 cases].

Li L, Liu YH, Zhuang HG, Luo XL, Zhang F, Xu FP, Luo DL. Li L, et al. Among authors: zhang f. Zhonghua Bing Li Xue Za Zhi. 2009 Apr;38(4):237-42. Zhonghua Bing Li Xue Za Zhi. 2009. PMID: 19575894 Chinese.

6

Justification of the change from 10% to 30% for the immunohistochemical HER2 Scoring criterion in breast cancer.

Liu YH, Xu FP, Rao JY, Zhuang HG, Luo XL, Li L, Luo DL, Zhang F, Xu J. Liu YH, et al. Among authors: zhang f. Am J Clin Pathol. 2009 Jul;132(1):74-9. doi: 10.1309/AJCPG3LCVKPNFJ6R. Am J Clin Pathol. 2009. PMID: 19864236

7

[Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].

Luo DL, Liu YH, Zhuang HG, Li L, Xu FP, Zhang F, Luo XL, Xu J. Luo DL, et al. Among authors: zhang f. Zhonghua Bing Li Xue Za Zhi. 2011 Apr;40(4):235-9. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 21615996 Chinese.

8

[Signaling pathways in pathogenesis of diffuse large B-cell lymphoma].

Zhang F, Xu FP, Liu YH, Zhuang HG. Zhang F, et al. Zhonghua Bing Li Xue Za Zhi. 2011 Apr;40(4):282-5. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 21616012 Review. Chinese. No abstract available.

9

[Association of HER2 protein expression with clinicopathologic features and prognosis in Chinese patients with gastric carcinoma].

Wu HM, Liu YH, Lin F, Xu FP, Luo DL, Zhang F, Zhuang HG, Luo XL, Wu WL, Lin XT. Wu HM, et al. Among authors: zhang f. Zhonghua Bing Li Xue Za Zhi. 2011 May;40(5):296-9. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 21756821 Chinese.

10

[Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].

Xu FP, Liu YH, Zhuang HG, Luo DL, Li L, Zhang F, Luo XL, Du X, Li WY, Chen Q. Xu FP, et al. Among authors: zhang f. Zhonghua Bing Li Xue Za Zhi. 2011 Sep;40(9):616-21. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 22177246 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36,518 results

Search Page

Filters